Vergoeding 2018-2022 voor ATC-subgroep A10BD : Combinaties van bloedglucoseverlagende middelen
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| A10BD02 Metformine met sulfonylureumderivaten (Glucovance ®) | 26.805 | 23.205 | 18.142 | 21.222 | 17.509 |
| A10BD05 Metformine met pioglitazon | 45.363 | 27.033 | 21.987 | 18.048 | 21.018 |
| A10BD07 Metformine met sitagliptine (Janumet ®) | 1.771.500 | 1.774.200 | 1.763.700 | 1.722.900 | 1.666.800 |
| A10BD08 Metformine met vildagliptine (Eucreas ®) | 1.492.400 | 1.468.300 | 1.455.400 | 1.363.100 | 1.323.100 |
| A10BD10 Metformine met saxagliptine | 11.240 | 1.076 | . | . | . |
| A10BD11 Metformine met linagliptine (Jentadueto ®) | 73.744 | 83.786 | 94.521 | 101.310 | 106.060 |
| A10BD15 Metformine met dapagliflozine (Xigduo ®) | 98.947 | 107.980 | 121.620 | 132.010 | 175.180 |
| A10BD16 Metformine met canagliflozine | 1.806 | 122 | . | . | . |
| A10BD20 Metformine met empagliflozine (Synjardy ®) | 126.290 | 136.560 | 154.390 | 160.070 | 223.750 |
| A10BD23 Metformine met ertugliflozine (Segluromet ®) | . | . | 349 | 21 | . |
| Totaal | 3.648.095 | 3.622.262 | 3.630.109 | 3.518.681 | 3.533.417 |